Candida albicans represents the most prevalent microbial population in mucosal and systemic infections, usually confined to severely immunocompromised people. Considering the increase of resistant strains and the demand for new antifungal drugs endowed with innovative mechanism of action, we performed a ligand-based virtual screening in order to identify new anti-Candida compounds. Starting from a large library of natural/semisynthetic products and several published synthesized compounds, three coumarin derivatives were discovered in silico as new hit compounds and submitted to the in vitro assay in order to confirm their predicted biological activity.

Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening / Gidaro, Concetta; Alcaro, Stefano; Secci, Daniela; Rivanera, Daniela; Mollica, Adriano; Agamennone, Mariangela; Giampietro, Letizia; Simone Carradori, And. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - STAMPA. - 31:6(2016), pp. 1703-1706. [10.3109/14756366.2016.1156103]

Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening

Daniela Secci;Daniela Rivanera;
2016

Abstract

Candida albicans represents the most prevalent microbial population in mucosal and systemic infections, usually confined to severely immunocompromised people. Considering the increase of resistant strains and the demand for new antifungal drugs endowed with innovative mechanism of action, we performed a ligand-based virtual screening in order to identify new anti-Candida compounds. Starting from a large library of natural/semisynthetic products and several published synthesized compounds, three coumarin derivatives were discovered in silico as new hit compounds and submitted to the in vitro assay in order to confirm their predicted biological activity.
2016
candida; coumarin; ligand-based approach; (thiazol-2-yl)hydrazines; virtual screening
01 Pubblicazione su rivista::01a Articolo in rivista
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening / Gidaro, Concetta; Alcaro, Stefano; Secci, Daniela; Rivanera, Daniela; Mollica, Adriano; Agamennone, Mariangela; Giampietro, Letizia; Simone Carradori, And. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - STAMPA. - 31:6(2016), pp. 1703-1706. [10.3109/14756366.2016.1156103]
File allegati a questo prodotto
File Dimensione Formato  
Gidaro_Identification_2016.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 756.84 kB
Formato Adobe PDF
756.84 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1019004
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 17
social impact